/ASBPW

ASBPW Stock - Aspire Biopharma Holdings, Inc.

Q: What is the analyst price target for ASBPW?

Analyst price target information is not currently available for ASBPW.

Q: What is ASBPW's market cap?

Market capitalization information is not currently available for ASBPW.

Healthcare|Biotechnology|NASDAQ

$0.03-0.31%

$0.00 (-0.31%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.04

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ASBPW

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2022

FY2023

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.87

52W High$0.04

52W Low$0.03

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022
Revenue	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A
Operating Income	$-3,088,671	$-1,340,168	$-976,345
Net Income	$-12,537,000	$4.46M	$-597,000
Net Margin	N/A	N/A	N/A
EPS	$-1.52	$0.54	$-0.07

Company Overview

Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.

Visit Website

Frequently Asked Questions about ASBPW

What is ASBPW's current stock price?

Aspire Biopharma Holdings, Inc. (ASBPW) is currently trading at $0.03 per share. The stock has moved -0.31% today.

What is the analyst price target for ASBPW?

No analyst price targets are currently available for this stock.

What sector is Aspire Biopharma Holdings, Inc. in?

Aspire Biopharma Holdings, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.

What is ASBPW's market cap?

Aspire Biopharma Holdings, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does ASBPW pay dividends?

No, Aspire Biopharma Holdings, Inc. does not currently pay a dividend to shareholders.